Bloomberg's The Business of Bad Medicine Column

Bloomberg's The Business of Bad Medicine column investigates andexplores how porous regulations and manufacturing shortcuts allow dangerous drugs to circulate around the world.

Key Coverage Featuring Valisure:

By The Numbers
  • $50 billion The size of India's pharmaceutical industry, the world's largest producer of generic drugs.
  • 900 The number of drug recalls issued by the FDA in 2022, triple the number four years ago.

Bloomberg's The Business of Bad Medicine Column

December 5, 2023

Bloomberg's The Business of Bad Medicine column investigates andexplores how porous regulations and manufacturing shortcuts allow dangerous drugs to circulate around the world.

Key Coverage Featuring Valisure:

By The Numbers
  • $50 billion The size of India's pharmaceutical industry, the world's largest producer of generic drugs.
  • 900 The number of drug recalls issued by the FDA in 2022, triple the number four years ago.

Bloomberg's The Business of Bad Medicine Column

Bloomberg's The Business of Bad Medicine column investigates andexplores how porous regulations and manufacturing shortcuts allow dangerous drugs to circulate around the world.

Key Coverage Featuring Valisure:

By The Numbers
  • $50 billion The size of India's pharmaceutical industry, the world's largest producer of generic drugs.
  • 900 The number of drug recalls issued by the FDA in 2022, triple the number four years ago.
Bloomberg's The Business of Bad Medicine column investigates andexplores how porous regulations and manufacturing shortcuts allow dangerous drugs to circulate around the world.

Key Coverage Featuring Valisure:

By The Numbers
  • $50 billion The size of India's pharmaceutical industry, the world's largest producer of generic drugs.
  • 900 The number of drug recalls issued by the FDA in 2022, triple the number four years ago.